Company: CNTB
Filing Date: 2025-07-17
Form Type: 8-K
Source: 0001835268-25-000039
Chunk: 0

Company: Connect Biopharma Holdings Ltd
Filing Date: 2025-07-17
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events.

On July 17, 2025, Connect Biopharma Holdings Limited (the “ Company”) announced that it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq”) notifying the Company that it has regained compliance with the minimum $1.00 per share requirement for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(a)(1) (the “ Minimum Bid Price Requirement”).

As previously disclosed, the Company received a letter dated March 24, 2025 from Nasdaq, indicating that it was not in compliance with the Minimum Bid Price Requirement because, for the last 30 consecutive business days, the bid price for the Company’s American Depositary Shares (“ ADSs”) had closed below $1.00 per share. The Company was provided 180 calendar days, or until September 22, 2025, to regain compliance with the Minimum Bid Price Requirement. To regain compliance with the Minimum Bid Price Requirement, the Company’s ADSs were required to maintain a closing bid price of $1.00 per share or greater for at least 10 consecutive business days. This requirement was met on July 15, 2025, and the matter is now closed.

Item 9.01 Financial Statements and Exhibits.